首页 | 本学科首页   官方微博 | 高级检索  
检索        


The rationale and design of the Beta‐blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
Authors:Matthew A Roberts  Helen L Pilmore  Francesco L Ierino  Sunil V Badve  Alan Cass  Amit X Garg  Carmel M Hawley  Nicole M Isbel  Henry Krum  Elaine M Pascoe  Andrew M Tonkin  Liza A Vergara  Vlado Perkovic  BLOCADE Study Collaborative Group
Institution:1. Department of Renal Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia;2. Department of Renal Medicine, Auckland City Hospital, Auckland, New Zealand;3. Department of Nephrology, Austin Health, Melbourne, Victoria, Australia;4. Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia;5. Australasian Kidney Trials Network, The University of Queensland, Brisbane, Queensland, Australia;6. Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia;7. Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia;8. Division of Nephrology, Department of Medicine, Western University, London, Ontario, Canada;9. Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia;10. Cardiovascular Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia;11. The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia
Abstract:
Keywords:beta‐blocking agent  feasibility study  haemodialysis  peritoneal dialysis  randomized controlled trial
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号